| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
S.v.p., General Counsel
1 company
Ozeroff Christopher David is a S.v.p., General Counsel at Oruka Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Buy | 50,000 | $2.26 | $113,210.00 | +5,155% | -11.7% | -6.7% | |
| Apr 4, 2017 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 418 | $2.41 | $1,007.38 | -2.3% | - | - | |
| Feb 28, 2017 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 465 | $2.61 | $1,213.65 | -2.5% | - | - | |
| Sep 20, 2016 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 1,185 | $2.89 | $3,424.65 | -6.1% | - | - | |
| Apr 5, 2016 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 366 | $3.52 | $1,288.32 | -1.8% | - | - | |
| Mar 1, 2016 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 458 | $3.51 | $1,607.58 | -2.2% | - | - | |
| Sep 18, 2015 | ORKA Oruka Therapeutics, Inc. | S.v.p., General Counsel | Sell | 1,129 | $6.32 | $7,135.28 | -5.2% | - | - |